Page 260 - Read Online

Nemtsova et al. Vessel Plus 2018;2:27 I http://dx.doi.org/10.20517/2574-1209.2018.48 Page 9 of 9

REFERENCES
1. Nilsson PM, Boutouyrie P, Laurent S. Vascular aging: a tale of EVA and ADAM in cardiovascular risk assessment and prevention.
Hypertension 2009;54:3-10.
2. Sinkevich DA, Protasov KV, Dzyzinsky AA. The concept of vascular age as a new approach to evaluation of cardiovascular risk.
Siberian Med J 2011;6:9-13.(in Russian)
3. Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part I: aging arteries: a “set
up” for vascular disease. Circulation 2003;107:139-46.
4. Luchikhina LV, Mendel OI, Mendel V, Golukhov GN. Osteoarthritis and age. Role of aging in the etiology and pathogenesis of the
disease. Mod rheumatology 2017;11:4-11. (in Russian)
5. Franceschi C, Capri M, Monti D, Giunta S, Olivieri F, Sevini F, Panourgia MP, Invidia L, Celani L, Scurti M, Cevenini E, Castellani
GC, Salvioli S. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans.
Mech Ageing Dev 2007;128:92-105.
6. Hammad EV, Belousova ON, Khmelnitsky AV, Poltoratsky AN, Shchekaturov AA. Modern biomaterials of aging for stratification of
risks associated with development of age-associated diseases (review) // Scientific Bulletins of BelSU. Series: medicine. Available
from: https://cyberleninka.ru/article/n/sovremennye-biomaterialy-stareniya-dlya-stratifikatsii-riskov-razvitiya-vozrast-assotsiirovannyh-
zabolevaniy-obzor-literatury. [Last accessed on 19 Sep 2018]
7. Kovalenko VM, Kornatsky VМ. Diseases of the circulatory system as a medical and social and socio-political problem (analytical and
statistical manual). Kiev; 2014. p. 279. (in Ukrainian)
8. Age classification of the World Health Organization. Available from: https://citifox.ru/2016/05/05/vozrastnaya-klassifikaciya-
vsemirnoy/. [Last accessed on 19 Sep 2018]
9. Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, Galderisi M,
Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PA, Sleight
P, Viigimaa M, Waeber B, Zannad F; Task Force Members. 2013 ESH/ESC guidelines for the management of arterial hypertension: the
task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of
Cardiology (ESC). J Hypertens 2013;31:1281-357.
10. Ministry of the Health of Ukraine. Order of the Ministry of Health of Ukraine dated 21.12.2012 № 1118 “on approval and
implementation of medical-technological documents for the standardization of medical aid in type 2 diabetes”. Available from: https://
medprosvita.com.ua/nakaz-moz-ukrayini-vid-21-12-2012-n-1118-pro-zatver/. [Last accessed on 19 Sep 2018]
11. Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, Peters AL, Tsapas A, Wender R, Matthews DR.
Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American
Diabetes Association and the European Association for the study of diabetes. Diabetes Care 2015;38:140-9.
12. Arutyunov AV, Dubinina EE, Zybina N.N. Methods for assessing free radical oxidation and the body’s antioxidant system. Guidelines.
St. Petersburg: IKF “Foliant”; 2000. p. 104 (in Russian)
13. Stein JH, Fraizer MC, Aeschlimann SE, Nelson-Worel J, McBride PE, Douglas PS. Vascular age: integrating carotid intima-media
thickness measurements with global coronary risk assessment. Clin Cardiol 2004;27:388-92.
14. Ostroumova OD, Zhukova OV, Erofeeva AG , Tolkalenov AV. Thickness of carotid arteries intima-media complex in patients with H -
the possibility of a fixed combination Logimax. Rus Med J 2009;8:548 (in Russian)
15. E.A.Prochorovich. Hypotensive therapy: a new combination and new possibilities. Consilium Medicum 2013;10:121-5.
16. Alireza Esteghamati, Delaram Eskandari, Hossein Mirmiranpour, Sina Noshad, Mostafa Mousavizadeh, Mehdi Hedayati, Manouchehr
Nakhjavan. Randomized clinical trial: the effect of metformin on markers of oxidative stress and antioxidant reserves in patients with
newly diagnosed type 2 diabetes. Obes Metabolism 2012;3:41-2.
17. Lodovici M, Bigagli E, Luceri C, Mannucci E, Rotella CM, Raimondi L. Gender-related drug effect on several markers of oxidation
stress in diabetes patients with and without complications. Eur J Pharmacol 2015;766:86-90.
18. Carracedo J, Ramírez-Carracedo R, Martínez de Toda I, Vida C, Alique M, De la Fuente M, Ramírez-Chamond R. Protein
carbamylation: a marker reflecting increased age-related cell oxidation. Int J Mol Sci 2018; doi: 10.3390/ijms19051495.
19. Wu LL, Chiou CC, Chang PY, Wu JT. Urinary 8-OH-dG: a marker of oxidative stress to DNA and a risk factor for cancer,
atherosclerosis and diabetics. Clin Chim Acta 2004;339:1-9.
20. Wang CC, Chen WL, Liou SH. P081 The difference between plasma and urinary 8-hydroxy-2-deoxyguanosine biomarkers measured by
liquid chromatrography tandem mass spectrometry. Occup Environ Med 2016;73:A147.